CapsoVision (CV) Cash from Operations (2024 - 2025)
CapsoVision (CV) posted Cash from Operations of 7686000.0 for Q4 2025, down 35.65% sequentially from 5666000.0 in Q3 2025, and down 42.36% YoY from 13334419.67 in Q4 2024.
CapsoVision (CV) Cash from Operations (2024 - 2025) Analysis & Trends
CapsoVision has reported Cash from Operations for 2 years, with the latest figure at 7686000.0 in Q4 2025.
- Quarterly Cash from Operations fell 42.36% year-over-year to 7686000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 25807000.0 (changed N/A YoY) and the FY2025 annual result came in at 22864000.0, down 13.8% from the prior year.
- Cash from Operations declined to 7686000.0 in Q4 2025 per CV's latest filing, from 5666000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 5399000.0 in Q4 2024 and troughed at 7686000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.39 Bn | 196.79 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Stryker | 126.37 Bn | 122.89 Bn | 4.50 Bn | 1.26 Bn |
| 3 | Medtronic | 119.28 Bn | 110.06 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.63 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.65 Bn | 47.40 Bn | 1.35 Bn | 651.90 Mn |
| 6 | Dexcom | 35.04 Bn | 33.10 Bn | 830.00 Mn | 269.20 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 168.00 Mn |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn | 437.05 Mn |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn | 367.10 Mn |
| 10 | CapsoVision | 301.62 Mn | 292.55 Mn | 1.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.69 Mn |
| Dec 31, 2025 | -7.69 Mn |
| Sep 30, 2025 | -5.67 Mn |
| Sep 30, 2025 | -5.67 Mn |
| Dec 31, 2024 | -5.40 Mn |
| Dec 31, 2024 | -5.40 Mn |
| Sep 30, 2024 | -7.06 Mn |
| Sep 30, 2024 | -7.06 Mn |